As an Immunology Therapeutic Area Biomarker Lead (TABL) you will lead disease area biomarker matrix teams and be accountable for the delivery of “fit for purpose” exploratory biomarker strategies across multiple programs in early and late clinical stages. In late phase particularly, you’ll be expected to assume the overall accountability for the biomarker strategy for at least one of our portfolio assets. You will be a core member of Project teams, involved in Global Biomarker and Diagnostic Teams, engaged in Translational Data Science teams, and provide therapeutic area line strategic, scientific and tactical input. As a TABL you will lead efforts to identify, develop, and drive disease, mechanistic and compound biology that serves the precision medicine hypotheses for the multi-indication portfolio.
In the role of TABL in Biomedical Research, Translational Medicine-Biomarker Development (BMD) you will be responsible for: [READ MORE]